Follow-On Biologics Is Pathway Not Taken, But House Cmte. Talks Continue

Energy and Commerce Health subcommittee members agreed Oct. 31 that there is not enough time left this session to pursue legislation addressing follow-on biologics

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet